Hatteras Venture Advisors III, LLC

CIK 1674177 · last filed 2018-10-24

Hatteras Venture Advisors III, LLC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for PHAS, was dated Oct 24, 2018. Across all open-market trades the lifetime net is +$13.3M, making them a net buyer over the disclosed history. The firm reports its address in Durham, NC. 5 SEC filings were submitted jointly with John Crumpler.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

2

Total Filings

2

Lifetime Open-Market Net

$13.25M

Filer Profile

Reported Address

280 S. MANGUM STREET, SUITE 350
DURHAM, NC 27701

Phone

(919) 484-0730

State of Incorporation

Related Filers

John Crumpler — 5 joint filings, latest 2018-10-24

ROBERT ALEXANDER INGRAM — 5 joint filings, latest 2018-10-24

KENNETH B LEE JR — 5 joint filings, latest 2018-10-24

Douglas MD Reed — 5 joint filings, latest 2018-10-24

Clay Thorp — 3 joint filings, latest 2017-01-19

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
PhaseBio Pharmaceuticals Inc (PHAS) Delisted	10%+ Owner	163,099	$0.07	$11.4K	$15.00M	1	2018-10-24
Clearside Biomedical, Inc. (CLSD) Delisted	10%+ Owner	117,181	$0.35	$41.2K	-$1.75M	1	2017-01-19

Recent Filings

2 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2018-10-24	PhaseBio Pharmaceuticals Inc (PHAS) Delisted	Mixed	+24,580,490	$15.00M	EDGAR
2017-01-19	Clearside Biomedical, Inc. (CLSD) Delisted	Sell (S)	−202,408	-$1.75M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.